A study of recent inspection observations allows for baseline trending and continuous improvement. (The opinions expressed in this article do not necessarily reflect FDA’s position on the matter being discussed.)
Lisa Tung
Advertisement
Lisa has a PharmD. ad M.P.H, and is a consumer safety officer at FDA. She can be reached at Lisa.Tung@fda.hhs.org.
Articles by Lisa Tung
Advertisement
Latest Updated Articles
Lessons Learned from FDA Inspections of Foreign API FacilitiesPublished: September 8th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
4
Sustainability and Stability in Excipients
5
